Cytosorbents Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cytosorbents Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Cytosorbents Corp Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $11.7M, a 4.46% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $11.7M -$544K -4.46% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $11.8M -$544K -4.41% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $11.9M -$545K -4.37% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $12.1M -$545K -4.32% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $12.2M -$598K -4.68% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $12.3M -$648K -4.99% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $12.5M -$727K -5.51% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $12.6M -$820K -6.11% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $12.8M -$857K -6.28% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $13M -$282K -2.13% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $13.2M +$12.3M +1328% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $13.4M +$12.4M +1204% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $13.7M +$12.5M +1106% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $13.3M +$12M +976% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $924K -$46.2K -4.76% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $1.03M -$41.6K -3.89% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.13M -$37.2K -3.18% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $1.23M -$32.8K -2.59% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $970K -$389K -28.6% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $1.07M -$379K -26.1% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $1.17M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $1.27M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $1.36M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $1.45M Dec 31, 2018 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.